Hepatitis C virus infection in children in the era of direct-acting antiviral

doi:10.3748/wjg.v24.i24.2555

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10499)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

904

HTML

6442

Figures (1-1)

276

Tables (1-2)

243

Sum=7865

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1238

Download

1396

Sum=2634

Jun 28, 2018 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 28, 2018; 24(24): 2555-2566
Published online Jun 28, 2018. doi: 10.3748/wjg.v24.i24.2555

Table 1 Ongoing clinical trials to evaluate the safety and efficacy of direct-acting antivirals in children with chronic hepatitis C

Trial identifier	Drug tested	HCV genotype
NCT 3067129	Glecaprevir/pibrentasvir	1-6
NCT 2486406	Ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin	1,4
NCT 3080415	Sofosbuvir + daclatasvir	4
NCT 2868242	Ledipasvir/sofosbuvir	1,4
NCT 2249182	Ledipasvir/sofosbuvir ± ribavirin	1,4,5,6
NCT 3022981	Sofosbuvir/velpatasvir	1-6
NCT 2985281	Gratisovir + ribavirin	1-6

HCV: Hepatitis C virus.

Citation: Pawlowska M, Sobolewska-Pilarczyk M, Domagalski K. Hepatitis C virus infection in children in the era of direct-acting antiviral. World J Gastroenterol 2018; 24(24): 2555-2566
URL: https://www.wjgnet.com/1007-9327/full/v24/i24/2555.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i24.2555